Atlas Trials

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Clinical trial NCT03782363 · WITHDRAWN

Trial details

NCT number
NCT03782363
Sponsor
Italian Sarcoma Group
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Sarcoma
Start date
2020-12-18
Primary completion
2023-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.